Therini Bio

Sacramento, CA · Founded 2016 · Privately Held (backing)

Developer of biotechnology drugs designed to offer a potential treatment to protect the nervous system from multiple sclerosis damage. Therini Bio is based in Sacramento, CA and was founded in 2016. It was valued at $100 million at its later-stage round in May 2025, the last priced event on record. It has raised $102 million across 2 recorded rounds; the latest was a $74.9 million later-stage round in Mar 2023.

PMV mark · valuation
$100.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$101.5M
Last round
Later Stage VC
Mar 2023
How much has Therini Bio raised?
$101.5Macross 2 recorded rounds · May 2019 – Mar 2023

Most recently, Therini Bio raised $74.9M in its Later Stage VC (Mar 2023).

Free account
More of Therini Bio with a free account
  • ·The complete investor list: 15 names
  • ·Watch Therini Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Therini Bio round by round

2 rounds
Mar 2023Later Stage VC$74.9MSEC filing▮
17 investors participated
May 2019Early Stage VC$9.4MSEC filing▮
4 investors participated

How much has Therini Bio raised?

Therini Bio has raised $102 million across 2 recorded rounds since 2019. The largest was a $9.4 million early-stage round in May 2019; the most recent was a $74.9 million later-stage round in Mar 2023.

Therini Bio has filed 3 Form Ds with the SEC since 2020, most recently in Sep 2025 ($74.9 million sold to 17 investors).

Therini Bio investors

15 investors are on record for Therini Bio, including National Institutes of Health, University of California, Dolby Family Ventures and SV Health Investors. The later-stage round in Mar 2023 drew 17 investors.

For fundraisers
Raising for a company like Therini Bio?

15 investors have backed Therini Bio.

See all 15 investors →

Frequently asked about Therini Bio

How much has Therini Bio raised?
Therini Bio has raised $101.5M in total across 2 recorded funding rounds.
When was Therini Bio's last funding round?
Therini Bio's most recent recorded round was Later Stage VC in Mar 2023, raising $74.9M.